Skip to main content
Project/Company Name

VANTAGE therapeutics Company Limited

Project Leader

Source of Funding/Programme

TSSSU


TSSSU Company

developing novel therapies targeting advanced glycation end products (AGEs), which play important pathological roles in chronic metabolic diseases and aging.
Project/Company Name

VANTAGE therapeutics Company Limited

Project Leader

Source of Funding/Programme

TSSSU

Description

developing novel therapies targeting advanced glycation end products (AGEs), which play important pathological roles in chronic metabolic diseases and aging.

Starting Year

2025

Business Area

Biotech

Nature

TSSSU Company